Published in Cancer Weekly, December 12th, 2000
The results were presented November 10, 2000, in Chicago, Illinois, at the Society for Neuro-Oncology meeting.
Forsyth and his colleagues were able to demonstrate in an athymic mouse model that Reolysin treatment of intracerebral tumors resulted in dramatic extension of life. In one set of investigations, 82% of treated animals were alive at 90 days at which point the experiment was terminated. Animals not receiving...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.